IBD: Co-medication does not affect Results of Approval Studies

被引：0
|
作者：
Klein, Friederike
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2025年 / 63卷 / 02期
关键词：
D O I：
10.1055/a-2447-9225
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In clinical Studies on Biologics or low-molecular-weight Active Substances, Participants with chronic inflammatory Bowel Disease (IBD) often receive other Drug Therapy in parallel with the Study Medication. An international Research Team with Lead Author Dhruv Ahuja from the Medical Clinic of the Indira Gandhi Hospital in New Delhi, India, examined whether this Concomitant Medication had an Influence on the Study Results
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [31] Effect of Co-Medication on the Pharmacokinetic Parameters of Phenobarbital in Asphyxiated Newborns
    Sima, M.
    Pokorna, P.
    Hronova, K.
    Slanar, O.
    PHYSIOLOGICAL RESEARCH, 2015, 64 : S513 - S519
  • [32] Objective assessment of nonadherence and unknown co-medication in hospitalized patients
    Carow, Florentine
    Rieger, Karin
    Walter-Sack, Ingeborg
    Meyer, Markus R.
    Peters, Frank T.
    Maurer, Hans H.
    Haefeli, Walter E.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (08) : 1191 - 1199
  • [33] Objective assessment of nonadherence and unknown co-medication in hospitalized patients
    Florentine Carow
    Karin Rieger
    Ingeborg Walter-Sack
    Markus R. Meyer
    Frank T. Peters
    Hans H. Maurer
    Walter E. Haefeli
    European Journal of Clinical Pharmacology, 2012, 68 : 1191 - 1199
  • [34] Co-medication in patients with severe psoriasis: first results of a retrospective analysis in 1203 hospitalized patients in Germany
    Zahl, V
    Gerdes, S
    Mrowietz, U
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01)
  • [35] Influence of age and co-medication on dolutegravir glucuronidation in paediatric patients
    Jacobs, Tom G.
    Waalewijn, Hylke
    Houlden, Lily
    Bollen, Pauline D. J.
    Nanduudu, Annet
    Nambi, Esether
    Cassim, Haseena
    Lugemwa, Abbas
    Makumbi, Shafic
    Monkiewicz, Lara N.
    Shakeshaft, Clare
    Bamford, Alasdair
    Archary, Moherndran
    Musuro, Godfrey
    Chidziva, Ennie
    Mujuru, Hilda A.
    Bwakura-Dangarembizi, Mutsa
    Chabala, Chishala
    Turkova, Anna
    Gibb, Di M.
    Cotton, Mark F.
    Aarnoutse, Rob
    Burger, David M.
    Colbers, Angela
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (11) : 2947 - 2952
  • [36] The comorbidity and co-medication profile of patients with progressive supranuclear palsy
    Stephan Greten
    Florian Wegner
    Ida Jensen
    Lea Krey
    Sophia Rogozinski
    Meret Fehring
    Johanne Heine
    Johanna Doll-Lee
    Monika Pötter-Nerger
    Molly Zeitzschel
    Keno Hagena
    David J. Pedrosa
    Carsten Eggers
    Katrin Bürk
    Claudia Trenkwalder
    Inga Claus
    Tobias Warnecke
    Patrick Süß
    Jürgen Winkler
    Doreen Gruber
    Florin Gandor
    Daniela Berg
    Steffen Paschen
    Joseph Classen
    Elmar H. Pinkhardt
    Jan Kassubek
    Wolfgang H. Jost
    Lars Tönges
    Andrea A. Kühn
    Johannes Schwarz
    Oliver Peters
    Eman Dashti
    Josef Priller
    Eike J. Spruth
    Patricia Krause
    Annika Spottke
    Anja Schneider
    Aline Beyle
    Okka Kimmich
    Markus Donix
    Robert Haussmann
    Moritz Brandt
    Elisabeth Dinter
    Jens Wiltfang
    Björn H. Schott
    Inga Zerr
    Mathias Bähr
    Katharina Buerger
    Daniel Janowitz
    Robert Perneczky
    Journal of Neurology, 2024, 271 : 782 - 793
  • [37] Optimising the tolerability of topiramate through reduction of antiepileptic co-medication
    Krämer, G
    Ramelli, GP
    Vogt, H
    Meyer, K
    Despland, PA
    Brändle, D
    EPILEPSIA, 2005, 46 : 113 - 114
  • [38] Co-medication management: key to optimize the efficacy and tolerability of Cenobamate
    Sanchez-Caro, J. M.
    Hariramani-Ramchandani, R.
    Maestro-Saiz, I.
    Abril-Jaramillo, J.
    Monge-Marquez, E.
    Perez-Diaz, H.
    Alonso-Vanegas, M.
    Rodriguez-Uranga, J.
    EPILEPSIA, 2023, 64 : 292 - 292
  • [39] Co-medication and potential drug interactions among patients with epilepsy
    Bosak, Magdalena
    Slowik, Agnieszka
    Iwanska, Anna
    Lipinska, Milena
    Turaj, Wojciech
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 66 : 47 - 52
  • [40] Co-medication management: key to optimize the efficacy and tolerability of Cenobamate
    Sanchez-Caro, J.
    Hariramani-Ramchandani, R.
    Maestro-Saiz, I.
    Abril-Jaramillo, J.
    Monge-Marquez, E.
    Perez-Diaz, H.
    Alonso-Vanegas, M.
    Rodriguez-Uranga, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 116 - 116
12345